Patent · US Active

Recombinant herpes zoster vaccine composition and application thereof

US12383616B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignee

IMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD. · CN

Inventors

Li Shi · Gaithersburg, US
Zhi Zhang · 红钢城街道, CN
Wenli TIAN · Shanghai, CN
Lin Liu · Gainesville, US
Xiaodong Sun · Shanghai, CN
Wei Yang · Longbeilingcun, CN
Wei Li · Songgang, CN

Key dates

Filing date	Jun 24, 2020
Grant date	Aug 12, 2025
Priority date	—
Expiry date	Jul 6, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/16743
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed in the present invention are a recombinant herpes zoster vaccine composition and an application thereof. Compared with other combinations of antigens and adjuvants, the novel vaccine composition provided by the present invention has a more beneficial immune effect.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.